Merck KgaA (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Darmstadt

The Merck Group, branded and commonly known as Merck, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, Germany. It also invests via M Ventures (Merck Ventures)

Average round investment:27.35M USD
Average number per year:1.0
Distribution: 2021 (1)2019 (1)
Portfolio companies: Germany Formo
Mostly invests in: Germany Germany (2) Biotech (2)

2 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Merck KgaA

Name Criteria
France AXA IM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Japan Rakuten Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland MTIP AG
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Hong Kong Happiness Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Obvious Ventures
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Luxembourg Vesalius Biocapital Partners
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Netherlands Merck Ventures
81%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United Kingdom Halma plc
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Data Collective (DCVC)
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Agronomics Limited
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top